Chris Wardle

Chris sits on the Hypha’s Investment Committee. Before co-founding the business, he spent more than a decade at Foresight Group. It was here that he met Matt Pomroy and Matt Evans-Young, who shared his passion for working closely with a small group of hand-picked SMEs with high potential and great management teams. 

This focus has resulted in Chris leading investments into numerous stellar successes including Codeplay Software, Envair Technology, Specac, Agar Scientific and Kingsbridge Healthcare Group, to name a few. 

Chris loves technology and the progress of science and culture, and how these all combine to create the future for humanity. This forward-looking approach means he can align with teams around a shared vision, providing a clear framework for strategic decisions that need to be made.